SCHEMBL14720732

SCHEMBL14720732

CC(=O)N1C2CCC1CC(O)(c1ccc(C=C3CCN(C4CCC4)CC3)cc1)C2

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
POLB P06746 1/20 0.40
SRD5A2 P31213 3/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
GRM5 P41594 1/20 0.34
HRH3 Q9Y5N1 4/20 0.33
HTT P42858 2/20 0.32
GAA P10253 1/20 0.32
MCHR1 Q99705 1/20 0.32
DRD2 P14416 2/20 0.31
DRD4 P21917 2/20 0.31
MEN1 O00255 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14723376 0.83 MEN1 (0.42) ALDH1A1SRD5A2HRH3MEN1KMT2A
SCHEMBL14720733 0.82 DRD2 (0.35) ALDH1A1POLBSRD5A2OPRM1OPRL1
SCHEMBL14720812 0.81 HRH3 (0.34) SRD5A2OPRM1OPRL1HRH3
SCHEMBL14721195 0.81 MEN1 (0.40) ALDH1A1SRD5A2HRH3MEN1KMT2A
SCHEMBL14721332 0.80 HRH3 (0.39) SRD5A2OPRM1OPRL1HRH3MEN1
SCHEMBL14721633 0.79 HRH3 (0.36) OPRM1OPRL1HRH3MEN1KMT2A
SCHEMBL14720765 0.79 KMT2A (0.38) ALDH1A1POLBHTTGAAMEN1
SCHEMBL14720774 0.79 HRH3 (0.40) SRD5A2OPRM1OPRL1HRH3MEN1
SCHEMBL14720563 0.79 OPRM1 (0.36) ALDH1A1POLBSRD5A2OPRM1MEN1
SCHEMBL14720457 0.78 HRH3 (0.33) ALDH1A1SRD5A2OPRM1OPRL1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed